In a report released today, Ravi Shanker from Morgan Stanley maintained a Sell rating on CH Robinson (CHRW – Research Report), with a price target of $67.00. The company’s shares opened today at $93.40.
According to TipRanks, Shanker is an analyst with an average return of -2.3% and a 48.76% success rate. Shanker covers the Industrial Goods sector, focusing on stocks such as CH Robinson, Allegiant Travel Company, and Delta Air Lines.
In addition to Morgan Stanley, CH Robinson also received a Sell from UBS’s Thomas Wadewitz in a report issued on January 4. However, today, Evercore ISI maintained a Hold rating on CH Robinson (NASDAQ: CHRW).
See today’s best-performing stocks on TipRanks >>
CHRW market cap is currently $10.99B and has a P/E ratio of 11.28.
Based on the recent corporate insider activity of 65 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CHRW in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
C.H. Robinson Worldwide, Inc. engages in the provision of freight transportation services and logistics solutions. It operates through the following three segments: North American Surface Transportation and Global Forwarding. The North American Surface Transportation segment provides freight transportation services across North America through a network of offices in the United States, Canada, and Mexico. The Global Forwarding segment provides global logistics services through an international network of offices in North America, Europe, Asia, Australia, New Zealand, and South America. The company was founded by Charles Henry Robinson in 1905 and is headquartered in Eden Prairie, MN.
Read More on CHRW:
- C.H. Robinson reaches standstill agreement with Ancora, WSJ reports
- C.H. Robinson downgraded to Neutral from Buy at Goldman Sachs
- C.H. Robinson price target lowered to $90 from $95 at BMO Capital
- Cowen downgrades C.H. Robinson into Q4 on ‘soft’ conditions
- C.H. Robinson downgraded to Market Perform from Outperform at Cowen